Dose-dependent nature of the interaction of fibrinogen-degradation products and 5-hydroxytryptamine on various vascular smooth muscle preparations [proceedings].
D000818:Animals; D004347:Drug Interactions; D005338:Fibrin Fibrinogen Degradation Products / Q000494:pharmacology*; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology*
D005338:Fibrin Fibrinogen Degradation Products; D012701:Serotonin